“Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report” (2024) Dermatology Practical & Conceptual, 14(4), p. e2024252. doi:10.5826/dpc.1404a252.